About MTOR-associated protein MEAK7
MTOR-associated protein MEAK7 (MEAK7) is a protein
from Homo sapiens identified by UniProt accession
Q6P9B6, 456 residues long.
MolForge cross-references it against 0 known binders and
38 disease associations.
Target properties
| Protein name | MTOR-associated protein MEAK7 |
| UniProt accession | Q6P9B6 |
| Gene | MEAK7 |
| Organism | Homo sapiens |
| Length | 456 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (38)
Diseases linked to this target (Open Targets).
- lymphocyte count · score 0.49
- monocyte count · score 0.48
- leukocyte count · score 0.47
- mean platelet volume · score 0.45
- myeloid white cell count · score 0.43
- neutrophil count · score 0.43
- basophil count · score 0.41
- mean corpuscular hemoglobin concentration · score 0.40
- HbA1c measurement · score 0.36
- platelet crit · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6P9B6-F1 | alphafold | PREDICTED | 86.33 | — |
Amino-acid sequence (456 residues)
MGNSRSRVGR SFCSQFLPEE QAEIDQLFDA LSSDKNSPNV SSKSFSLKAL QNHVGEALPP EMVTRLYDGM RRVDLTGKAK GPSENVSQEQ FTASMSHLLK GNSEEKSLMI MKMISATEGP VKAREVQKFT EDLVGSVVHV LSHRQELRGW TGKEAPGPNP RVQVLAAQLL SDMKLQDGKR LLGPQWLDYD CDRAVIEDWV FRVPHVAIFL SVVICKGFLI LCSSLDLTTL VPERQVDQGR GFESILDVLS VMYINAQLPR EQRHRWCLLF SSELHGHSFS QLCGHITHRG PCVAVLEDHD KHVFGGFASC SWEVKPQFQG DNRCFLFSIC PSMAVYTHTG YNDHYMYLNH GQQTIPNGLG MGGQHNYFGL WVDVDFGKGH SRAKPTCTTY NSPQLSAQEN FQFDKMEVWA VGDPSEEQLA KGNKSILDAD PEAQALLEIS GHSRHSEGLR EVPDDE
Explore MTOR-associated protein MEAK7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets